img

Global and United States Equine Drugs and Supplement Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Equine Drugs and Supplement Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and United States Equine Drugs and Supplement Market
This report focuses on global and United States Equine Drugs and Supplement market, also covers the segmentation data of other regions in regional level and county level.
The global Equine Drugs and Supplement revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period (2024-2034).
In United States the Equine Drugs and Supplement revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Equine Drugs and Supplement include Bayer Animal Health, Boehringer Ingelheim, Elanco (Eli Lilly), Merck Animal Health, Merial, Novartis Animal Health and Zoetis, etc. The global five biggest players hold a share of % in 2024.
Global Equine Drugs and Supplement Scope and Market Size
Equine Drugs and Supplement market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Equine Drugs and Supplement market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For United States market, this report focuses on the Equine Drugs and Supplement market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Bayer Animal Health
Boehringer Ingelheim
Elanco (Eli Lilly)
Merck Animal Health
Merial
Novartis Animal Health
Zoetis
Segment by Type
Supplements
Pharmaceutical Drugs

Segment by Application


Drugstores
Veterinary Hospitals
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Equine Drugs and Supplement definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Equine Drugs and Supplement companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Equine Drugs and Supplement in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Equine Drugs and Supplement sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Equine Drugs and Supplement Product Introduction
1.2 Global Equine Drugs and Supplement Outlook 2018 VS 2024 VS 2034
1.2.1 Global Equine Drugs and Supplement Sales in US$ Million for the Year 2018-2034
1.2.2 Global Equine Drugs and Supplement Sales in Volume for the Year 2018-2034
1.3 United States Equine Drugs and Supplement Outlook 2018 VS 2024 VS 2034
1.3.1 United States Equine Drugs and Supplement Sales in US$ Million for the Year 2018-2034
1.3.2 United States Equine Drugs and Supplement Sales in Volume for the Year 2018-2034
1.4 Equine Drugs and Supplement Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of United States Equine Drugs and Supplement in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Equine Drugs and Supplement Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.5 Equine Drugs and Supplement Market Dynamics
1.5.1 Equine Drugs and Supplement Industry Trends
1.5.2 Equine Drugs and Supplement Market Drivers
1.5.3 Equine Drugs and Supplement Market Challenges
1.5.4 Equine Drugs and Supplement Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Equine Drugs and Supplement by Type
2.1 Equine Drugs and Supplement Market Segment by Type
2.1.1 Supplements
2.1.2 Pharmaceutical Drugs
2.2 Global Equine Drugs and Supplement Market Size by Type
2.2.1 Global Equine Drugs and Supplement Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Equine Drugs and Supplement Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Equine Drugs and Supplement Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 United States Equine Drugs and Supplement Market Size by Type
2.3.1 United States Equine Drugs and Supplement Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 United States Equine Drugs and Supplement Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 United States Equine Drugs and Supplement Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Equine Drugs and Supplement by Application
3.1 Equine Drugs and Supplement Market Segment by Application
3.1.1 Drugstores
3.1.2 Veterinary Hospitals
3.1.3 Others
3.2 Global Equine Drugs and Supplement Market Size by Application
3.2.1 Global Equine Drugs and Supplement Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Equine Drugs and Supplement Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Equine Drugs and Supplement Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 United States Equine Drugs and Supplement Market Size by Application
3.3.1 United States Equine Drugs and Supplement Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 United States Equine Drugs and Supplement Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 United States Equine Drugs and Supplement Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Equine Drugs and Supplement Competitor Landscape by Company
4.1 Global Equine Drugs and Supplement Market Size by Company
4.1.1 Global Key Manufacturers of Equine Drugs and Supplement, Ranked by Revenue (2024)
4.1.2 Global Equine Drugs and Supplement Revenue by Manufacturer (2018-2023)
4.1.3 Global Equine Drugs and Supplement Sales by Manufacturer (2018-2023)
4.1.4 Global Equine Drugs and Supplement Price by Manufacturer (2018-2023)
4.2 Global Equine Drugs and Supplement Concentration Ratio (CR)
4.2.1 Equine Drugs and Supplement Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Equine Drugs and Supplement in 2024
4.2.3 Global Equine Drugs and Supplement Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Equine Drugs and Supplement, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Equine Drugs and Supplement, Product Offered and Application
4.5 Global Key Manufacturers of Equine Drugs and Supplement, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Equine Drugs and Supplement Market Size by Company
4.7.1 Key Players of Equine Drugs and Supplement in United States, Ranked by Revenue (2024)
4.7.2 United States Equine Drugs and Supplement Revenue by Players (2018-2023)
4.7.3 United States Equine Drugs and Supplement Sales by Players (2018-2023)
5 Global Equine Drugs and Supplement Market Size by Region
5.1 Global Equine Drugs and Supplement Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Equine Drugs and Supplement Market Size in Volume by Region (2018-2034)
5.2.1 Global Equine Drugs and Supplement Sales in Volume by Region: 2018-2023
5.2.2 Global Equine Drugs and Supplement Sales in Volume Forecast by Region (2024-2034)
5.3 Global Equine Drugs and Supplement Market Size in Value by Region (2018-2034)
5.3.1 Global Equine Drugs and Supplement Sales in Value by Region: 2018-2023
5.3.2 Global Equine Drugs and Supplement Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Equine Drugs and Supplement Market Size YoY Growth 2018-2034
6.2 Americas Equine Drugs and Supplement Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Equine Drugs and Supplement Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Equine Drugs and Supplement Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Equine Drugs and Supplement Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Equine Drugs and Supplement Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Equine Drugs and Supplement Market Size YoY Growth 2018-2034
7.2 EMEA Equine Drugs and Supplement Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Equine Drugs and Supplement Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Equine Drugs and Supplement Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Equine Drugs and Supplement Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Equine Drugs and Supplement Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Equine Drugs and Supplement Market Size YoY Growth 2018-2034
8.2 China Equine Drugs and Supplement Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Equine Drugs and Supplement Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Equine Drugs and Supplement Market Size YoY Growth 2018-2034
9.2 APAC Equine Drugs and Supplement Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Equine Drugs and Supplement Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Equine Drugs and Supplement Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Equine Drugs and Supplement Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Equine Drugs and Supplement Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Bayer Animal Health
10.1.1 Bayer Animal Health Company Information
10.1.2 Bayer Animal Health Description and Business Overview
10.1.3 Bayer Animal Health Equine Drugs and Supplement Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bayer Animal Health Equine Drugs and Supplement Products Offered
10.1.5 Bayer Animal Health Recent Development
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Company Information
10.2.2 Boehringer Ingelheim Description and Business Overview
10.2.3 Boehringer Ingelheim Equine Drugs and Supplement Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Boehringer Ingelheim Equine Drugs and Supplement Products Offered
10.2.5 Boehringer Ingelheim Recent Development
10.3 Elanco (Eli Lilly)
10.3.1 Elanco (Eli Lilly) Company Information
10.3.2 Elanco (Eli Lilly) Description and Business Overview
10.3.3 Elanco (Eli Lilly) Equine Drugs and Supplement Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Elanco (Eli Lilly) Equine Drugs and Supplement Products Offered
10.3.5 Elanco (Eli Lilly) Recent Development
10.4 Merck Animal Health
10.4.1 Merck Animal Health Company Information
10.4.2 Merck Animal Health Description and Business Overview
10.4.3 Merck Animal Health Equine Drugs and Supplement Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Merck Animal Health Equine Drugs and Supplement Products Offered
10.4.5 Merck Animal Health Recent Development
10.5 Merial
10.5.1 Merial Company Information
10.5.2 Merial Description and Business Overview
10.5.3 Merial Equine Drugs and Supplement Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Merial Equine Drugs and Supplement Products Offered
10.5.5 Merial Recent Development
10.6 Novartis Animal Health
10.6.1 Novartis Animal Health Company Information
10.6.2 Novartis Animal Health Description and Business Overview
10.6.3 Novartis Animal Health Equine Drugs and Supplement Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Novartis Animal Health Equine Drugs and Supplement Products Offered
10.6.5 Novartis Animal Health Recent Development
10.7 Zoetis
10.7.1 Zoetis Company Information
10.7.2 Zoetis Description and Business Overview
10.7.3 Zoetis Equine Drugs and Supplement Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Zoetis Equine Drugs and Supplement Products Offered
10.7.5 Zoetis Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Equine Drugs and Supplement Industry Chain Analysis
11.2 Equine Drugs and Supplement Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Equine Drugs and Supplement Production Mode & Process
11.4 Equine Drugs and Supplement Sales and Marketing
11.4.1 Equine Drugs and Supplement Sales Channels
11.4.2 Equine Drugs and Supplement Distributors
11.5 Equine Drugs and Supplement Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Equine Drugs and Supplement CAGR in Value, United States VS Global, 2018 VS 2024 VS 2034
Table 2. Equine Drugs and Supplement Market Trends
Table 3. Equine Drugs and Supplement Market Drivers
Table 4. Equine Drugs and Supplement Market Challenges
Table 5. Equine Drugs and Supplement Market Restraints
Table 6. Global Equine Drugs and Supplement Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Equine Drugs and Supplement Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Equine Drugs and Supplement Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Equine Drugs and Supplement Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Equine Drugs and Supplement, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Equine Drugs and Supplement Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Equine Drugs and Supplement Revenue Share by Manufacturer, 2018-2023
Table 13. Global Equine Drugs and Supplement Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Equine Drugs and Supplement Sales Share by Manufacturer, 2018-2023
Table 15. Global Equine Drugs and Supplement Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Equine Drugs and Supplement Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Equine Drugs and Supplement by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Drugs and Supplement as of 2024)
Table 18. Global Key Manufacturers of Equine Drugs and Supplement, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Equine Drugs and Supplement, Product Offered and Application
Table 20. Global Key Manufacturers of Equine Drugs and Supplement, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Equine Drugs and Supplement in United States, Ranked by Revenue (2024) & (US$ million)
Table 23. United States Equine Drugs and Supplement Revenue by Players, (US$ Million), (2018-2023)
Table 24. United States Equine Drugs and Supplement Revenue Share by Players, (2018-2023)
Table 25. United States Equine Drugs and Supplement Sales by Players, (K Units), (2018-2023)
Table 26. United States Equine Drugs and Supplement Sales Share by Players, (2018-2023)
Table 27. Global Equine Drugs and Supplement Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Equine Drugs and Supplement Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Equine Drugs and Supplement Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Equine Drugs and Supplement Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Equine Drugs and Supplement Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Equine Drugs and Supplement Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Equine Drugs and Supplement Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Equine Drugs and Supplement Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Equine Drugs and Supplement Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Equine Drugs and Supplement Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Equine Drugs and Supplement Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Equine Drugs and Supplement Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Equine Drugs and Supplement Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Equine Drugs and Supplement Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Equine Drugs and Supplement Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Equine Drugs and Supplement Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Equine Drugs and Supplement Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Equine Drugs and Supplement Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Equine Drugs and Supplement Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Equine Drugs and Supplement Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Bayer Animal Health Company Information
Table 48. Bayer Animal Health Description and Business Overview
Table 49. Bayer Animal Health Equine Drugs and Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Bayer Animal Health Equine Drugs and Supplement Product
Table 51. Bayer Animal Health Recent Development
Table 52. Boehringer Ingelheim Company Information
Table 53. Boehringer Ingelheim Description and Business Overview
Table 54. Boehringer Ingelheim Equine Drugs and Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Boehringer Ingelheim Equine Drugs and Supplement Product
Table 56. Boehringer Ingelheim Recent Development
Table 57. Elanco (Eli Lilly) Company Information
Table 58. Elanco (Eli Lilly) Description and Business Overview
Table 59. Elanco (Eli Lilly) Equine Drugs and Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Elanco (Eli Lilly) Equine Drugs and Supplement Product
Table 61. Elanco (Eli Lilly) Recent Development
Table 62. Merck Animal Health Company Information
Table 63. Merck Animal Health Description and Business Overview
Table 64. Merck Animal Health Equine Drugs and Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Merck Animal Health Equine Drugs and Supplement Product
Table 66. Merck Animal Health Recent Development
Table 67. Merial Company Information
Table 68. Merial Description and Business Overview
Table 69. Merial Equine Drugs and Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Merial Equine Drugs and Supplement Product
Table 71. Merial Recent Development
Table 72. Novartis Animal Health Company Information
Table 73. Novartis Animal Health Description and Business Overview
Table 74. Novartis Animal Health Equine Drugs and Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Novartis Animal Health Equine Drugs and Supplement Product
Table 76. Novartis Animal Health Recent Development
Table 77. Zoetis Company Information
Table 78. Zoetis Description and Business Overview
Table 79. Zoetis Equine Drugs and Supplement Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Zoetis Equine Drugs and Supplement Product
Table 81. Zoetis Recent Development
Table 82. Key Raw Materials Lists
Table 83. Raw Materials Key Suppliers Lists
Table 84. Equine Drugs and Supplement Customers List
Table 85. Equine Drugs and Supplement Distributors List
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Equine Drugs and Supplement Product Picture
Figure 2. Global Equine Drugs and Supplement Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Equine Drugs and Supplement Market Size 2018-2034 (US$ Million)
Figure 4. Global Equine Drugs and Supplement Sales 2018-2034 (K Units)
Figure 5. United States Equine Drugs and Supplement Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. United States Equine Drugs and Supplement Market Size 2018-2034 (US$ Million)
Figure 7. United States Equine Drugs and Supplement Sales 2018-2034 (K Units)
Figure 8. United States Equine Drugs and Supplement Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. United States Equine Drugs and Supplement Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Equine Drugs and Supplement Report Years Considered
Figure 11. Product Picture of Supplements
Figure 12. Product Picture of Pharmaceutical Drugs
Figure 13. Global Equine Drugs and Supplement Market Share by Type in 2024 & 2034
Figure 14. Global Equine Drugs and Supplement Sales in Value by Type (2018-2034) & (US$ Million)
Figure 15. Global Equine Drugs and Supplement Sales Market Share in Value by Type (2018-2034)
Figure 16. Global Equine Drugs and Supplement Sales by Type (2018-2034) & (K Units)
Figure 17. Global Equine Drugs and Supplement Sales Market Share in Volume by Type (2018-2034)
Figure 18. Global Equine Drugs and Supplement Price by Type (2018-2034) & (US$/Unit)
Figure 19. United States Equine Drugs and Supplement Market Share by Type in 2024 & 2034
Figure 20. United States Equine Drugs and Supplement Sales in Value by Type (2018-2034) & (US$ Million)
Figure 21. United States Equine Drugs and Supplement Sales Market Share in Value by Type (2018-2034)
Figure 22. United States Equine Drugs and Supplement Sales by Type (2018-2034) & (K Units)
Figure 23. United States Equine Drugs and Supplement Sales Market Share in Volume by Type (2018-2034)
Figure 24. United States Equine Drugs and Supplement Price by Type (2018-2034) & (US$/Unit)
Figure 25. Product Picture of Drugstores
Figure 26. Product Picture of Veterinary Hospitals
Figure 27. Product Picture of Others
Figure 28. Global Equine Drugs and Supplement Market Share by Application in 2024 & 2034
Figure 29. Global Equine Drugs and Supplement Sales in Value by Application (2018-2034) & (US$ Million)
Figure 30. Global Equine Drugs and Supplement Sales Market Share in Value by Application (2018-2034)
Figure 31. Global Equine Drugs and Supplement Sales by Application (2018-2034) & (K Units)
Figure 32. Global Equine Drugs and Supplement Sales Market Share in Volume by Application (2018-2034)
Figure 33. Global Equine Drugs and Supplement Price by Application (2018-2034) & (US$/Unit)
Figure 34. United States Equine Drugs and Supplement Market Share by Application in 2024 & 2034
Figure 35. United States Equine Drugs and Supplement Sales in Value by Application (2018-2034) & (US$ Million)
Figure 36. United States Equine Drugs and Supplement Sales Market Share in Value by Application (2018-2034)
Figure 37. United States Equine Drugs and Supplement Sales by Application (2018-2034) & (K Units)
Figure 38. United States Equine Drugs and Supplement Sales Market Share in Volume by Application (2018-2034)
Figure 39. United States Equine Drugs and Supplement Price by Application (2018-2034) & (US$/Unit)
Figure 40. Americas Equine Drugs and Supplement Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 41. Americas Equine Drugs and Supplement Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 42. Americas Equine Drugs and Supplement Sales by Type (2018-2034) & (K Units)
Figure 43. Americas Equine Drugs and Supplement Sales Market Share in Volume by Type (2018-2034)
Figure 44. Americas Equine Drugs and Supplement Sales by Application (2018-2034) & (K Units)
Figure 45. Americas Equine Drugs and Supplement Sales Market Share in Volume by Application (2018-2034)
Figure 46. United States Equine Drugs and Supplement Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 47. Canada Equine Drugs and Supplement Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 48. Mexico Equine Drugs and Supplement Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil Equine Drugs and Supplement Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. EMEA Equine Drugs and Supplement Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 51. EMEA Equine Drugs and Supplement Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 52. EMEA Equine Drugs and Supplement Sales by Type (2018-2034) & (K Units)
Figure 53. EMEA Equine Drugs and Supplement Sales Market Share in Volume by Type (2018-2034)
Figure 54. EMEA Equine Drugs and Supplement Sales by Application (2018-2034) & (K Units)
Figure 55. EMEA Equine Drugs and Supplement Sales Market Share in Volume by Application (2018-2034)
Figure 56. Europe Equine Drugs and Supplement Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 57. Middle East Equine Drugs and Supplement Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 58. Africa Equine Drugs and Supplement Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 59. China Equine Drugs and Supplement Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 60. China Equine Drugs and Supplement Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 61. China Equine Drugs and Supplement Sales by Type (2018-2034) & (K Units)
Figure 62. China Equine Drugs and Supplement Sales Market Share in Volume by Type (2018-2034)
Figure 63. China Equine Drugs and Supplement Sales by Application (2018-2034) & (K Units)
Figure 64. China Equine Drugs and Supplement Sales Market Share in Volume by Application (2018-2034)
Figure 65. APAC Equine Drugs and Supplement Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 66. APAC Equine Drugs and Supplement Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 67. APAC Equine Drugs and Supplement Sales by Type (2018-2034) & (K Units)
Figure 68. APAC Equine Drugs and Supplement Sales Market Share in Volume by Type (2018-2034)
Figure 69. APAC Equine Drugs and Supplement Sales by Application (2018-2034) & (K Units)
Figure 70. APAC Equine Drugs and Supplement Sales Market Share in Volume by Application (2018-2034)
Figure 71. Japan Equine Drugs and Supplement Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 72. South Korea Equine Drugs and Supplement Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 73. China Taiwan Equine Drugs and Supplement Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Equine Drugs and Supplement Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. India Equine Drugs and Supplement Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. Equine Drugs and Supplement Value Chain
Figure 77. Equine Drugs and Supplement Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed